Acetaminophen (Paracetamol) Improves Pain and Well-Being in People With Advanced Cancer Already Receiving a Strong Opioid Regimen: A Randomized, Double-Blind, Placebo-Controlled Cross-Over Trial

医学 对乙酰氨基酚 安慰剂 养生 类阿片 随机对照试验 癌症疼痛 麻醉 癌症 内科学 替代医学 病理 受体
作者
Martin R. Stockler,Janette L. Vardy,Avinesh Pillai,David G. Warr
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:22 (16): 3389-3394 被引量:146
标识
DOI:10.1200/jco.2004.09.122
摘要

PURPOSE: To determine whether adding regular acetaminophen (paracetamol) could improve pain and well-being in people with advanced cancer and pain despite strong opioids. PATIENTS AND METHODS: Participants took acetaminophen for 48 hours and placebo for 48 hours. The order (acetaminophen or placebo first) was randomly allocated. Pain was the primary outcome. Preferences, number of opioid breakthrough doses, overall well-being, nausea and vomiting, drowsiness, constipation, and cold sweats were secondary outcomes. Patients rated themselves daily with visual analog scales (VAS) and a verbal numeric scale (VNS) for pain, all scaled from 0 to 10. RESULTS: Thirty patients completed the trial. The oral opioid was morphine in 23 patients and hydromorphone in seven patients. The median daily opioid dose in oral morphine equivalents was 200 mg (range, 20 to 2,100 mg). Nonsteroidal anti-inflammatory drugs, corticosteroids, or both were used by 16 patients. Pain and overall well-being were better for patients receiving acetaminophen than for those receiving placebo. The mean difference was 0.4 (95% CI, 0.1 to 0.8; P =.03) in VNS for pain, 0.6 (95% CI, -0.1 to 1.3; P =.09) in VAS for pain, and 0.7 (95% CI, 0.0 to 1.4; P =.05) in VAS for overall well-being. More patients preferred the period they took acetaminophen (n = 14) than the period they took placebo (n = 8), but many had no preference (n = 8). There were no differences in the other outcomes. CONCLUSION: Acetaminophen improved pain and well-being without major side effects in patients with cancer and persistent pain despite a strong opioid regimen. Its addition is worth considering in all such patients.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
小年糕完成签到,获得积分10
刚刚
1秒前
CWJ发布了新的文献求助10
1秒前
1秒前
1秒前
前行的灿发布了新的文献求助10
2秒前
fty完成签到,获得积分10
3秒前
sube完成签到,获得积分10
3秒前
酷波er的应助被方超采纳,获得10
3秒前
服了完成签到,获得积分10
3秒前
开心的盼波完成签到 ,获得积分10
3秒前
张晨宸发布了新的文献求助10
4秒前
flash完成签到,获得积分10
4秒前
4秒前
4秒前
Hurlee发布了新的文献求助10
4秒前
ccss发布了新的文献求助10
4秒前
5秒前
5秒前
SciGPT的应助被Chr15采纳,获得20
5秒前
Alvienan发布了新的文献求助20
5秒前
Arain456完成签到 ,获得积分10
5秒前
5秒前
6秒前
怡然的扬发布了新的文献求助10
6秒前
无极微光的应助被柠柠采纳,获得20
6秒前
6秒前
欣喜的涵柏完成签到 ,获得积分10
6秒前
科研艾完成签到 ,获得积分10
7秒前
怕黑的手链完成签到 ,获得积分10
7秒前
淡淡觅波完成签到,获得积分10
7秒前
满意的小猫咪完成签到,获得积分10
7秒前
云望北完成签到,获得积分10
7秒前
小鱼哈哈完成签到,获得积分10
8秒前
cdragon完成签到,获得积分10
8秒前
大可完成签到 ,获得积分10
8秒前
所所的应助被姜渡采纳,获得10
8秒前
感性的神级完成签到,获得积分0
8秒前
糖果完成签到,获得积分10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Social Psychology in the Real World 600
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8180713
求助须知:如何正确求助?哪些是违规求助? 9570752
关于积分的说明 21814119
捐赠科研通 7776960
什么是DOI,文献DOI怎么找? 3433298
关于科研通互助平台的介绍 2557579
邀请新用户注册赠送积分活动 2479287